N/A N=54 Postoperative Virtual Clinical Encounters
Pelvic Organ Prolapse
Primary: Patient Satisfaction Via the Patient Satisfaction Questionnaire -18 — 80.7; 81.2 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=10 Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance
Abdominal Adhesions
Primary: Completion of Diagnostic Peritineoscopy — 8 Participants
Phase 4 N=72 Intra-operative Digital vs. Standard Mammography
Breast Cancer
Primary: Comparison of Operative Time Savings — 48.5; 54; 68; 74 Minutes — p=0.716
N/A N=374 The Extended Operations And Pelvic Muscle Training In The Management Of Apical Support Loss Study
Pelvic Organ Prolapse
Primary: Surgical Failure — 17; 22; 20; 14 Participants
N/A N=103 Visits Versus Telephone Calls for Postoperative Care
Satisfaction · Postoperative Complications · Pelvic Floor Disorder
Primary: Patient Satisfaction — 43; 42; 43; 45 participants
N/A N=72 Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease
Degenerative Lumbar Disease
Primary: Postoperative Complications in the BMI Groups During Post Operative Hospitalization. — 8; 9; 20 Events during hospitalization
N/A N=80 3D Versus 2D Laparoscopic Ovarian Cystectomy
Surgical Procedure, Unspecified
Primary: The Duration of Laparoscopic Ovarian Cystectomy — 51.6; 47.6 minutes — p=0.198
N/A N=4 Apollo Overstitch, a Treat and Resect Model
Colon Malignant Tumor · Colon Benign Tumor
Primary: Successful Suture Approximation With Cinching Device — 3.57 score on a scale
Early Phase 1 N=103 Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Cervical Cancer · Uterine Endometrial Cancer · Ovarian Cancer
Primary: Hospital Stay — 3.0; 3.0 Days — p=0.36
N/A N=374 Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
Pelvic Organ Prolapse (POP)
Primary: Surgical Success — 25; 30; 28; 27 Participants
N/A N=278 Transoral Robotic Surgery for rECurrent Tumours of the Upper Aerodigestive Tract
Recurrent Head and Neck Cancer
Primary: Disease-free Survival at 2 Years — 111 Participants
N/A N=150 Gastric Procedures for Obesity
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
Phase 4 N=786 Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)
Opioid Use · Pain, Postoperative
Primary: Total 30 Day Post-discharge Home Opioid Use (Number of Tablets) — 10.00; 10.00; 6.18; 6.67 tablets — p=0.970
N/A N=33 Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study
Oropharyngeal Cancer
Primary: Performance — 0 Participants
Phase 4 N=129 Toward Zero Prescribed Opioids for Outpatient General Surgery
Opioid Misuse and Addiction · Pain
Primary: Morphine Milligram Equivalents Taken by Participants — 46; 15; 0 morphine milligram equivalents
N/A N=72 Balloon Sinus Dilation In Office or OR
Chronic Sinusitis
Primary: Mean Intra-patient Change in SNOT-20 Score at 24 Weeks Post-procedure Compared to Baseline — -1.25; -1.35 scores on a scale
N/A N=4,021 South African Surgical Outcomes Study
Mortality Following Noncardiac Surgery
Primary: Mortality — 123 participants
N/A N=77 SCP Hip Outcomes Study
Subchondral Cysts · Subchondral Bone Edema · Bone Marrow Edema
Primary: Overall Group Mean Improvement From Baseline of the Modified Harris Hip Score (mHHS) at 2 Years — 25.8; 26.3; 24.8 score on a scale
N/A N=50 Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand
Epithelial Ovarian Cancer
Primary: Surgical Time — 417; 338 SECONDS
N/A N=10 On-pump Intraoperative Echocardiography
Septal Myectomy
Primary: Septal Thickness Measured Before Cardiopulmonary Bypass — 22.9; 22.5 millimeters
N/A N=180 Operative and Non-operative Treatment of Traumatic Arthrotomies
Traumatic Arthrotomy
Primary: Cost of Treatments — 1089; 11,973 USD
N/A N=90 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
Synchronous Metastasized Breast Cancer · Circulating Tumor Cells
Primary: Overall Survival (OS) — 34.6; 56.2 months — p=0.042
N/A N=25 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
Peripheral Artery Disease · PAD · Claudication
Primary: Rate of Clinically Driven Target Lesion Revascularization (TLR) — 4.0; 8.2 % probablity of clinically driven TLR
N/A N=129 STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial
Postoperative Pain · Opioid Use · Prolapse; Female
Primary: Percentage of Patients Satisfied With Pain Control at 6 Week Postoperative Visit — 59; 58 Participants
N/A N=443 Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
Coronary Artery Disease
Primary: Primary Safety Endpoint: 30-Day Freedom From Major Adverse Cardiac Events (MACE) — 89.6 Percent probability of Freedom from MACE
N/A N=40 Surgical Theater's Surgery Rehearsal Platform
Cerebral Aneurysm Unruptured · Cerebral Aneurysm Ruptured
Primary: Aneurysm Clip Time
N/A N=20 Osia CPT Code Study
Conductive Hearing Loss · Mixed Hearing Loss
Primary: Change From Baseline in Adaptive Speech in Noise Test Score for Osia 2 System at 3 Months Post-surgery — 6.1 Score on a scale
N/A N=446 PCORI-1502-27462 Navigating High Risk Surgery: Empowering Older Adults to Ask Questions That Inform Decisions About Surgical Treatment
Communication
Primary: Patient Engagement in Decision Making Measured by Clinic Visit Transcript Coding for Number of and Types of Questions Raised — 68; 55; 95; 89 Participants — p=0.353
N/A N=70 Hysterectomy by Transabdominal Laparoscopy or NOTES
Uterine Diseases
Primary: Successful Removal of the Uterus Without Conversion to Another Technique — 35; 35 Participants — p=0.0221
N/A N=1,590 Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
Vaginal Prolapse
Primary: Count of Patients With at Least One Adverse Event Related to Any AMS Prolapse Device — 194 participants